Journal article
Transfusion implications in a COVID-19 era
Australasian Anaesthesia, Vol.2021, pp.147-155
2021
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) resulting in COVID-19 has had major consequences internationally. Originally a third of COVID-19 patients in the UK were estimated to die. By 17 July 2021, according to the WHO (World Health Organization) dashboard, there were 188,655,968 confirmed cases and 4,067,517 deaths related to COVID-19. The consequences to transfusion practice, treatment and blood product supply implications were assessed by Stanworth et al (Lancet 2020) during a systematic review of published literature (considering more than 9000 citations and including 121 citations). Other implications of transfusion alternatives, and the ability to use viscoelastic testing in addition to standard laboratory measurements when managing transfusion and coagulation in COVID-19 patients were considered in this review.
Details
- Title
- Transfusion implications in a COVID-19 era
- Authors
- Michelle Roets - University of QueenslandDavid John Sturgess - University of QueenslandMelinda Dean - University of the Sunshine Coast, Queensland, School of Health - Biomedicine
- Publication details
- Australasian Anaesthesia, Vol.2021, pp.147-155
- Publisher
- Australian and New Zealand College of Anaesthetists
- Organisation Unit
- School of Health - Biomedicine
- Language
- English
- Record Identifier
- 991042798702621
- Output Type
- Journal article
Metrics
1 Record Views